피브린 실란트 시장 규모, 점유율, 성장 분석 : 제품 유형별, 기술별, 용도별, 최종 사용자별, 지역별 - 업계 예측(2026-2033년)

Global Fibrin Sealants Market size was valued at USD 639.15 Million in 2024 and is poised to grow from USD 689 Million in 2025 to USD 1256.52 Million by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global fibrin sealants market is primarily driven by the increasing volume of surgical procedures, influenced by an aging population prone to chronic illnesses that necessitate surgery, including cardiovascular and orthopedic conditions. As complex surgeries rise, the reliance on effective hemostatic agents like fibrin sealants grows due to their ability to quickly form stable clots and enhance tissue sealing, ultimately reducing blood loss and recovery times. A significant trend within the market is the advancement of biologic and recombinant DNA technologies, yielding safer and more effective sealants with longer shelf lives and lower immunogenic risks. Enhanced manufacturing processes enable the creation of synthetic, pathogen-free products, while innovative formulations improve adhesion and polymerization speed, thereby broadening the clinical use and acceptance of fibrin sealants in surgical settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fibrin Sealants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fibrin Sealants Market Segments Analysis

Global Fibrin Sealants Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into Liquid, Patches, Powder and Others. Based on Technology, the market is segmented into Viral Inactivation, Autologous Donation, Recombinant Production and Others. Based on Application, the market is segmented into Orthopedic Surgery, Cardiovascular surgery, General Surgery, Transplant Surgery and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fibrin Sealants Market

The increasing prevalence of surgical interventions across the globe serves as a major catalyst for the expansion of the global fibrin sealants market. A rise in chronic health conditions, such as heart diseases, cancer, and orthopedic issues, boosts the demand for effective hemostatic solutions, like fibrin sealants, during surgical procedures. This heightened need for reliable and efficient surgical tools plays a crucial role in propelling market development, as healthcare providers seek advanced options to improve patient outcomes and enhance the efficiency of operations. Consequently, the growing emphasis on innovative medical solutions further stimulates market dynamics.

Restraints in the Global Fibrin Sealants Market

The growth of the global fibrin sealants market is hindered by regulatory challenges and protracted approval procedures for these products. The requirement for comprehensive clinical trials and adherence to regulatory standards across various regions extends development timelines, which in turn restricts the introduction of new products into the market. This situation may discourage the availability of cutting-edge fibrin sealant solutions, ultimately affecting the overall market dynamics and innovation in the field. As companies navigate these obstacles, the potential for timely access to advanced offerings remains constrained, impacting both manufacturers and consumers seeking effective wound management options.

Market Trends of the Global Fibrin Sealants Market

The Global Fibrin Sealants market is witnessing a significant uptick fueled by the escalating preference for minimally invasive surgical techniques. As healthcare providers aim to enhance patient outcomes, fibrin sealants are increasingly recognized for their capacity to facilitate quicker recovery times, minimize blood loss, and improve overall surgical results. Their versatility in applications, especially within the fields of cardiovascular and orthopedics, underscores their critical role in procedures where precision and rapid recovery are paramount. This growing demand not only highlights a shift in surgical practices but also signals a broader trend towards advanced materials that support effective healing and patient wellbeing.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Fibrin Sealants Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Liquid
  • Frozen fibrin sealants
  • Freeze dried fibrin sealants
• Patches
• Powder
• Others

Global Fibrin Sealants Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Viral Inactivation
• Autologous Donation
• Recombinant Production
• Others

Global Fibrin Sealants Market Size by Application & CAGR (2026-2033)

• Market Overview
• Orthopedic Surgery
• Cardiovascular surgery
• General Surgery
• Transplant Surgery
• Others

Global Fibrin Sealants Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Fibrin Sealants Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Baxter International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vivostat A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemarus (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Z-Medica (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marquee Biosurgical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corza Medical (USA/Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Medical Solutions Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocular Therapeutix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVal (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations